International Assets Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

International Assets Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$1.13K	–	2402
2026 Q1	$1.13K	Buy	+6	New	+$1.05K	﹤0.01%	2051
2024 Q4	–	Sell	-540	Closed	-$60.2K	–	1340
2024 Q3	$60.2K	Buy	+540	New	+$59.2K	﹤0.01%	1002
2021 Q2	–	Sell	-22	Closed	-$4K	–	1193
2021 Q1	$4K	Hold	22	–	–	﹤0.01%	1848
2020 Q4	$4K	Buy	+22	New	+$3.28K	﹤0.01%	1701

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

International Assets Investment Management's JAZZ Position: Q2 2026 in Review

International Assets Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 6 shares — an estimated $1.13K sold.

International Assets Investment Management first reported a position in JAZZ in Q4 2020 and held it in 4 quarters. The position peaked at $60.2K in Q3 2024. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

International Assets Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
International Assets Investment Management sold 6 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.13K.
International Assets Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 4 quarters.
International Assets Investment Management's Jazz Pharmaceuticals position peaked at $60.2K in Q3 2024.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.